Boric acid enhances the antitumor effects of paclitaxel by modulating apoptosis, autophagy-related protein expression, and proinflammatory cytokine expression in OVCAR-3 ovarian cancer cells
Turkish Journal of Medical Sciences · 13.08.2026 · 56 (4) · 1332-1342
DOI: 10.55730/1300-0144.6377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 13.08.2026. Verfasst von Nazmiye Bitgen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye. Hauptthemen laut MEDLINE: Boric Acids, Paclitaxel, Apoptosis, Ovarian Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Ovarian cancer is the eighth most prevalent malignancy among women globally and ranks third among gynecological cancers in terms of incidence. The limited efficacy of standard chemotherapy, primarily due to intrinsic drug resistance and high recurrence rates, highlights the urgent need for novel therapeutic strategies that are both effective and selectively cytotoxic. Materials and methods: This study aimed to investigate the combined effects of boric acid (BA), a biologically active boron compound with emerging antitumor potential, and paclitaxel (PTX), a conventional chemotherapeutic agent, on cell viability, cell cycle progression, apoptosis, autophagy-related protein expression, and inflammatory signaling in the chemoresistant OVCAR-3 ovarian cancer cell line. OVCAR-3 cells were treated with increasing concentrations of BA over varying time periods. The half-maximal inhibitory concentrations (IC₅₀) of both BA and PTX were determined using the MTT assay. Flow cytometry was employed to assess cell cycle distribution and apoptosis via Annexin V staining. Additionally, immunofluorescence staining was performed to evaluate the expression of autophagy-related proteins (Beclin-1, LC3, and p62) and proinflammatory cytokines (TNF-α, IL-6, and IL-1β).
Results
The combination of BA and PTX resulted in significant G₀/G₁ phase cell cycle arrest and a marked increase in apoptotic cell death and the expression of autophagy-related proteins, leading to reduced cell viability in OVCAR-3 cells. Furthermore, cotreatment significantly modulated the expression of proinflammatory cytokines, suggesting a potential immunomodulatory effect associated with the observed cytotoxicity.
Conclusion
The findings of this study provide evidence that boric acid enhances the antitumor efficacy of paclitaxel in drug-resistant ovarian cancer cells through coordinated modulation of cell cycle progression, apoptosis, autophagy-related protein expression, and inflammatory signaling. These findings support the potential of BA as a promising adjuvant for combination chemotherapy in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
- Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkiye.
- Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye.
- Department of Basic Science, Faculty of Pharmacy, Erciyes University, Kayseri, Turkiye.
- Department of Medical Biology, Institute of Health Sciences, Erciyes University, Kayseri, Turkiye.
- Department of Molecular Biology and Genetics, Gevher Nesibe Genome and Stem Cell Institute, Erciyes University, Kayseri, Turkiye.
ORCID-Profile: Nazmiye Bitgen, Gözde Özge Önder, Münevver Baran, Fatma Esen Karakuş, Melike Akbulut, Arzu Yay
Zitieren
APA
Bitgen, N., Önder, G. Ö., Baran, M., Karakuş, F. E., Akbulut, M., & Yay, A. (2026). Boric acid enhances the antitumor effects of paclitaxel by modulating apoptosis, autophagy-related protein expression, and proinflammatory cytokine expression in OVCAR-3 ovarian cancer cells . Turkish Journal of Medical Sciences, 56(4), 1332-1342. https://doi.org/10.55730/1300-0144.6377
Vancouver
Bitgen N, Önder GÖ, Baran M, Karakuş FE, Akbulut M, Yay A. Boric acid enhances the antitumor effects of paclitaxel by modulating apoptosis, autophagy-related protein expression, and proinflammatory cytokine expression in OVCAR-3 ovarian cancer cells . Turkish Journal of Medical Sciences. 2026;56(4):1332-1342. doi:10.55730/1300-0144.6377
BibTeX
@article{Bitgen2026,
author = {Bitgen, Nazmiye and Önder, Gözde Özge and Baran, Münevver and Karakuş, Fatma Esen and Akbulut, Melike and Yay, Arzu},
title = {Boric acid enhances the antitumor effects of paclitaxel by modulating apoptosis, autophagy-related protein expression, and proinflammatory cytokine expression in OVCAR-3 ovarian cancer cells },
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {4},
pages = {1332--1342},
doi = {10.55730/1300-0144.6377}
}
EUVIMED